<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046709"><TermName>defibrotide</TermName><TermPronunciation>(dee-FY-broh-tide)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the prevention of veno-occlusive disease, a rare complication of high-dose chemotherapy and stem cell transplantation in which small veins in the liver become blocked.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731739" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;defibrotide&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731738" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;defibrotide&quot;" language="es" id="_4"/><SpanishTermName>defibrotide</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para la prevención de la enfermedad veno-oclusiva, una complicación poco común de la quimioterapia y el trasplante de células madre de dosis alta por la que se bloquean las venas pequeñas del hígado.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2003-10-16</DateLastModified></GlossaryTerm>
